SI-BONE (SIBN) Stock Forecast, Price Target & Predictions
SIBN Stock Forecast
SI-BONE stock forecast is as follows: an average price target of $20.00 (represents a 27.15% upside from SIBN’s last price of $15.73) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
SIBN Price Target
The average price target for SI-BONE (SIBN) is $20.00 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $25.00 to $18.00. This represents a potential 27.15% upside from SIBN's last price of $15.73.
SIBN Analyst Ratings
According to 8 Wall Street analysts, SI-BONE's rating consensus is 'Buy'. The analyst rating breakdown for SIBN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (75.00%), 2 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
SI-BONE Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 06, 2024 | Samuel Brodovsky | Truist Financial | $18.00 | $14.04 | 28.21% | 14.43% |
| Aug 06, 2024 | David Saxon | Needham | $19.00 | $14.36 | 32.31% | 20.79% |
| Mar 28, 2024 | Matt O'Brien | Piper Sandler | $25.00 | $15.82 | 58.03% | 58.93% |
| Jul 12, 2023 | David Saxon | Needham | $32.00 | $26.93 | 18.83% | 103.43% |
| Jan 06, 2023 | - | Morgan Stanley | $18.00 | $12.58 | 43.08% | 14.43% |
| Dec 20, 2022 | - | Truist Financial | $17.00 | $11.77 | 44.50% | 8.07% |
| May 16, 2022 | Drew Ranieri | Morgan Stanley | $22.00 | $12.50 | 76.00% | 39.86% |
The latest SI-BONE stock forecast, released on Aug 06, 2024 by Samuel Brodovsky from Truist Financial, set a price target of $18.00, which represents a 28.21% increase from the stock price at the time of the forecast ($14.04), and a 14.43% increase from SIBN last price ($15.73).
SI-BONE Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 3 |
| Avg Price Target | - | $18.50 | $20.67 |
| Last Closing Price | $15.73 | $15.73 | $15.73 |
| Upside/Downside | -100.00% | 17.61% | 31.40% |
In the current month, the average price target of SI-BONE stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SI-BONE's last price of $15.73. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 06, 2024 | Needham | Buy | Buy | Hold |
| May 07, 2024 | Needham | Underperform | Underperform | Hold |
| May 07, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 07, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Mar 28, 2024 | Piper Sandler | Buy | Buy | Hold |
| Mar 28, 2024 | Piper Sandler | - | Overweight | Initialise |
| Feb 27, 2024 | Truist Financial | Buy | Buy | Hold |
| Dec 22, 2023 | Needham | Buy | Buy | Hold |
| Nov 07, 2023 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Jul 12, 2023 | Needham | Buy | Buy | Hold |
SI-BONE's last stock rating was published by Needham on Aug 06, 2024. The company gave SIBN a "Buy" rating, the same as its previous rate.
SI-BONE Financial Forecast
SI-BONE Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $34.01M | $33.30M | $32.71M | $31.95M | $26.43M | - | $22.44M | $25.23M | $22.29M | $22.19M | $20.44M | $22.14M | $20.37M | $14.05M | $16.82M | $19.81M | $16.18M |
| Avg Forecast | $64.59M | $56.69M | $56.29M | $53.40M | $54.23M | $47.63M | $47.05M | $44.93M | $47.58M | $40.49M | $39.10M | $36.49M | $37.92M | $32.38M | $31.21M | $29.17M | $31.50M | $26.43M | $25.17M | $21.87M | $24.71M | $22.49M | $21.74M | $18.93M | $22.08M | $16.51M | $8.78M | $17.87M | $19.29M | $16.27M |
| High Forecast | $65.08M | $57.12M | $56.72M | $53.81M | $54.65M | $48.00M | $47.41M | $45.28M | $47.94M | $40.82M | $39.40M | $36.77M | $38.21M | $32.63M | $31.45M | $29.40M | $31.74M | $26.63M | $25.17M | $22.23M | $25.12M | $22.87M | $22.11M | $19.24M | $22.45M | $16.79M | $8.93M | $18.17M | $19.61M | $16.54M |
| Low Forecast | $64.13M | $56.28M | $55.89M | $53.02M | $53.84M | $47.29M | $46.72M | $44.61M | $47.24M | $40.00M | $38.82M | $36.23M | $37.65M | $32.15M | $30.99M | $28.96M | $31.28M | $26.24M | $25.17M | $21.73M | $24.55M | $22.35M | $21.61M | $18.81M | $21.95M | $16.41M | $8.73M | $17.76M | $19.17M | $16.17M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 5 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.07% | 1.12% | 1.01% | 1.00% | - | 1.03% | 1.02% | 0.99% | 1.02% | 1.08% | 1.00% | 1.23% | 1.60% | 0.94% | 1.03% | 0.99% |
SI-BONE's average Quarter revenue forecast for Dec 23 based on 4 analysts is $37.92M, with a low forecast of $37.65M, and a high forecast of $38.21M. SIBN's average Quarter revenue forecast represents a 11.47% increase compared to the company's last Quarter revenue of $34.01M (Sep 23).
SI-BONE EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 5 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-11.17M | $-10.36M | $-10.29M | $-10.29M | $-13.40M | - | $-16.14M | $-13.26M | $-12.62M | $-12.40M | $-10.84M | $-7.55M | $-8.09M | $-9.53M | $-11.29M | $-7.65M | $-9.89M |
| Avg Forecast | $-31.33M | $-27.50M | $-27.31M | $-25.90M | $-26.31M | $-23.11M | $-22.82M | $-21.80M | $-23.08M | $-19.64M | $-18.97M | $-15.46M | $-18.39M | $-15.71M | $-15.14M | $-14.05M | $-15.28M | $-11.90M | $-12.21M | $-12.77M | $-11.90M | $-10.82M | $-11.45M | $-11.65M | $-10.71M | $-9.34M | $-12.51M | $-8.62M | $-9.36M | $-7.48M |
| High Forecast | $-31.11M | $-27.30M | $-27.11M | $-25.72M | $-26.12M | $-22.94M | $-22.66M | $-21.64M | $-22.91M | $-19.40M | $-18.83M | $-12.36M | $-18.26M | $-15.59M | $-15.03M | $-11.24M | $-15.17M | $-9.52M | $-12.21M | $-10.22M | $-9.52M | $-8.66M | $-9.16M | $-9.32M | $-10.65M | $-7.47M | $-10.01M | $-6.89M | $-9.30M | $-5.99M |
| Low Forecast | $-31.57M | $-27.71M | $-27.52M | $-26.10M | $-26.51M | $-23.28M | $-23.00M | $-21.96M | $-23.26M | $-19.80M | $-19.11M | $-18.55M | $-18.53M | $-15.83M | $-15.26M | $-16.86M | $-15.40M | $-14.28M | $-12.21M | $-15.33M | $-14.28M | $-12.98M | $-13.74M | $-13.98M | $-10.89M | $-11.20M | $-15.01M | $-10.34M | $-9.51M | $-8.98M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.71% | 0.68% | 0.73% | 0.67% | 1.13% | - | 1.26% | 1.11% | 1.17% | 1.08% | 0.93% | 0.70% | 0.87% | 0.76% | 1.31% | 0.82% | 1.32% |
undefined analysts predict SIBN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than SI-BONE's previous annual EBITDA (undefined) of $NaN.
SI-BONE Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 5 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-10.02M | $-11.21M | $-10.12M | $-11.06M | $-14.75M | - | $-17.95M | $-15.02M | $-15.87M | $-13.98M | $-12.24M | $-10.09M | $-9.47M | $-12.47M | $-12.77M | $-9.71M | $-11.31M |
| Avg Forecast | $-1.52M | $-5.23M | $-5.85M | $-7.51M | $-6.26M | $-8.28M | $-8.29M | $-9.31M | $-7.21M | $-9.87M | $-11.44M | $-16.66M | $-11.49M | $-14.15M | $-16.37M | $-15.14M | $-16.51M | $-14.97M | $-20.05M | $-13.77M | $-15.68M | $-13.60M | $-12.91M | $-13.16M | $-12.26M | $-10.93M | $-16.37M | $-9.75M | $-14.15M | $-8.56M |
| High Forecast | $-1.50M | $-5.18M | $-5.80M | $-7.44M | $-6.21M | $-8.21M | $-8.22M | $-9.23M | $-7.14M | $-8.97M | $-11.34M | $-13.33M | $-10.70M | $-14.02M | $-16.22M | $-12.11M | $-16.36M | $-11.97M | $-20.05M | $-11.01M | $-15.55M | $-10.88M | $-10.32M | $-10.53M | $-12.16M | $-8.75M | $-13.10M | $-7.80M | $-14.03M | $-6.84M |
| Low Forecast | $-1.53M | $-5.28M | $-5.91M | $-7.59M | $-6.33M | $-8.37M | $-8.38M | $-9.41M | $-7.28M | $-11.22M | $-11.56M | $-19.99M | $-12.28M | $-14.29M | $-16.53M | $-18.17M | $-16.67M | $-17.96M | $-20.05M | $-16.52M | $-16.02M | $-16.33M | $-15.49M | $-15.79M | $-12.52M | $-13.12M | $-19.64M | $-11.70M | $-14.46M | $-10.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.71% | 0.68% | 0.67% | 0.67% | 0.99% | - | 1.30% | 0.96% | 1.17% | 1.08% | 0.93% | 0.82% | 0.87% | 0.76% | 1.31% | 0.69% | 1.32% |
SI-BONE's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SIBN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
SI-BONE SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 5 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $34.22M | $35.29M | $34.79M | $34.68M | $32.74M | - | $32.74M | $32.74M | $29.72M | $29.64M | $26.86M | $25.31M | $23.69M | $19.91M | $24.68M | $24.47M | $23.26M |
| Avg Forecast | $80.38M | $70.55M | $70.06M | $66.46M | $67.50M | $59.28M | $58.56M | $55.92M | $59.21M | $50.39M | $48.67M | $31.33M | $47.19M | $40.30M | $38.85M | $28.48M | $39.21M | $32.90M | $31.33M | $27.22M | $30.75M | $27.99M | $27.06M | $23.56M | $27.48M | $20.55M | $10.93M | $22.23M | $24.00M | $20.24M |
| High Forecast | $81.00M | $71.09M | $70.60M | $66.97M | $68.01M | $59.74M | $59.01M | $56.35M | $59.67M | $50.80M | $49.04M | $37.59M | $47.55M | $40.61M | $39.14M | $34.18M | $39.51M | $33.15M | $31.33M | $27.67M | $31.26M | $28.46M | $27.51M | $23.95M | $27.95M | $20.89M | $11.12M | $22.61M | $24.41M | $20.58M |
| Low Forecast | $79.81M | $70.05M | $69.56M | $65.98M | $67.01M | $58.86M | $58.14M | $55.52M | $58.79M | $49.78M | $48.32M | $25.06M | $46.85M | $40.01M | $38.57M | $22.78M | $38.93M | $32.66M | $31.33M | $27.05M | $30.56M | $27.82M | $26.89M | $23.41M | $27.31M | $20.42M | $10.87M | $22.10M | $23.85M | $20.12M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 0.91% | 1.22% | 0.88% | 1.00% | - | 1.20% | 1.06% | 1.06% | 1.10% | 1.14% | 0.92% | 1.15% | 1.82% | 1.11% | 1.02% | 1.15% |
SI-BONE's average Quarter SG&A projection for Dec 23 is $47.19M, based on 4 Wall Street analysts, with a range of $46.85M to $47.55M. The forecast indicates a 37.89% rise compared to SIBN last annual SG&A of $34.22M (Sep 23).
SI-BONE EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 5 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.25 | $-0.30 | $-0.29 | $-0.32 | $-0.43 | - | $-0.53 | $-0.45 | $-0.56 | $-0.45 | $-0.39 | $-0.32 | $-0.36 | $-0.52 | $-0.50 | $-0.39 | $-0.49 |
| Avg Forecast | $-0.04 | $-0.13 | $-0.14 | $-0.18 | $-0.15 | $-0.20 | $-0.20 | $-0.23 | $-0.17 | $-0.24 | $-0.28 | $-0.31 | $-0.28 | $-0.34 | $-0.40 | $-0.41 | $-0.40 | $-0.47 | $-0.49 | $-0.43 | $-0.39 | $-0.42 | $-0.40 | $-0.40 | $-0.30 | $-0.39 | $-0.64 | $-0.38 | $-0.35 | $-0.37 |
| High Forecast | $-0.04 | $-0.13 | $-0.14 | $-0.18 | $-0.15 | $-0.20 | $-0.20 | $-0.22 | $-0.17 | $-0.22 | $-0.27 | $-0.31 | $-0.26 | $-0.34 | $-0.39 | $-0.41 | $-0.40 | $-0.47 | $-0.49 | $-0.42 | $-0.38 | $-0.41 | $-0.39 | $-0.40 | $-0.30 | $-0.38 | $-0.63 | $-0.38 | $-0.35 | $-0.37 |
| Low Forecast | $-0.04 | $-0.13 | $-0.14 | $-0.18 | $-0.15 | $-0.20 | $-0.20 | $-0.23 | $-0.18 | $-0.27 | $-0.28 | $-0.31 | $-0.30 | $-0.35 | $-0.40 | $-0.42 | $-0.40 | $-0.48 | $-0.49 | $-0.44 | $-0.39 | $-0.43 | $-0.41 | $-0.41 | $-0.31 | $-0.40 | $-0.65 | $-0.39 | $-0.36 | $-0.38 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.73% | 0.76% | 0.70% | 0.80% | 0.91% | - | 1.24% | 1.16% | 1.34% | 1.13% | 0.98% | 1.06% | 0.93% | 0.81% | 1.30% | 1.12% | 1.32% |
According to undefined Wall Street analysts, SI-BONE's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SIBN previous annual EPS of $NaN (undefined).
SI-BONE Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| RPID | Rapid Micro Biosystems | $0.84 | $8.00 | 852.38% | Hold |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| ESTA | Establishment Labs | $44.20 | $78.00 | 76.47% | Buy |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
| CNMD | CONMED | $75.40 | $101.00 | 33.95% | Buy |
| SIBN | SI-BONE | $15.73 | $20.00 | 27.15% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| RXST | RxSight | $54.96 | $68.60 | 24.82% | Buy |
| IRMD | IRadimed | $48.47 | $60.00 | 23.79% | Buy |
| TCMD | Tactile Systems | $13.86 | $16.00 | 15.44% | Buy |
| ITGR | Integer | $126.78 | $131.00 | 3.33% | Buy |
SIBN Forecast FAQ
Is SI-BONE a good buy?
Yes, according to 8 Wall Street analysts, SI-BONE (SIBN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 75.00% of SIBN's total ratings.
What is SIBN's price target?
SI-BONE (SIBN) average price target is $20 with a range of $18 to $25, implying a 27.15% from its last price of $15.73. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will SI-BONE stock go up soon?
According to Wall Street analysts' prediction for SIBN stock, the company can go up by 27.15% (from the last price of $15.73 to the average price target of $20), up by 58.93% based on the highest stock price target, and up by 14.43% based on the lowest stock price target.
Can SI-BONE stock reach $20?
SIBN's highest twelve months analyst stock price target of $25 supports the claim that SI-BONE can reach $20 in the near future.
What are SI-BONE's analysts' financial forecasts?
SI-BONE's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $193.85M (high $195.34M, low $192.46M), average EBITDA is $-94.033M (high $-93.36M, low $-94.753M), average net income is $-32.155M (high $-31.855M, low $-32.475M), average SG&A $241.26M (high $243.11M, low $239.53M), and average EPS is $-0.778 (high $-0.771, low $-0.786). SIBN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $230.97M (high $232.74M, low $229.32M), average EBITDA is $-112M (high $-111M, low $-113M), average net income is $-20.105M (high $-19.918M, low $-20.305M), average SG&A $287.46M (high $289.66M, low $285.4M), and average EPS is $-0.487 (high $-0.482, low $-0.491).
Did the SIBN's actual financial results beat the analysts' financial forecasts?
Based on SI-BONE's last annual report (Dec 2023), the company's revenue was $138.89M, beating the average analysts forecast of $130.68M by 6.28%. Apple's EBITDA was $-46.931M, missing the average prediction of $-63.29M by -25.85%. The company's net income was $-43.336M, missing the average estimation of $-57.155M by -24.18%. Apple's SG&A was $141.32M, missing the average forecast of $154.81M by -8.71%. Lastly, the company's EPS was $-0.0011, missing the average prediction of $-1.429 by -99.92%. In terms of the last quarterly report (Sep 2023), SI-BONE's revenue was $34.01M, beating the average analysts' forecast of $32.38M by 5.05%. The company's EBITDA was $-11.169M, missing the average prediction of $-15.706M by -28.89%. SI-BONE's net income was $-10.022M, missing the average estimation of $-14.149M by -29.17%. The company's SG&A was $34.22M, missing the average forecast of $40.3M by -15.07%. Lastly, the company's EPS was $-0.25, missing the average prediction of $-0.342 by -26.99%